Correction: Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label randomised controlled ORAL Surveillance trial
- PMID: 37726134
- PMCID: PMC10511951
- DOI: 10.1136/ard-2022-222405corr1
Correction: Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label randomised controlled ORAL Surveillance trial
Erratum for
-
Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial.Ann Rheum Dis. 2022 Nov;81(11):1491-1503. doi: 10.1136/ard-2022-222405. Epub 2022 Aug 3. Ann Rheum Dis. 2022. PMID: 35922124 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
